Table 3. Proportion of patients undergoing treatment according to fitness as defined by Complete Geriatric Assessment (N=301).
|
Patient fitness
|
|||||
|---|---|---|---|---|---|
|
Fit
|
Unfit
|
X 2 P -value | |||
| Treatment | N | % | N | % | |
| Breast surgery | 132/(132) | 100% | 156/(171) | 91% | 0.0002 |
| Patients undergoing axillary surgery | 122/(132) | 92% | 144/(171) | 84% | 0.0340 |
| Adjuvant radiotherapy after WLE | 82/(93) | 88% | 86/(96) | 90% | 0.8195 |
| High risk patients receiving chemotherapy | 39/(76) | 51% | 18/(91) | 20% | 0.0001 |
| HER2-positive patients receiving Trastuzumaba | 14/(21) | 67% | 11/(19) | 58% | 0.7451 |
| ER-positive receiving endocrine therapy | 102 (115) | 89% | 131/(151) | 87% | 0.7451 |
Abbreviations: ER = oestrogen receptor; HER2 = human epidermal growth factor receptor 2; WLE = wide local excision.
a
Three unfit patients received adjuvant Herceptin with no concomitant chemotherapy. Statistically significant P-values are shown in bold.